Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc. et al
Case Number:
5:24-cv-03567
See also:
Court:
Nature of Suit:
Judge:
Firms
Companies
- Aetna Inc.
- Corcept Therapeutics Inc.
- Health Care Service Corp.
- Humana Inc.
- Molina Healthcare Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
September 15, 2025
Corcept Can't Escape Teva's Mifepristone Antitrust Suit
Corcept Therapeutics must face most of Teva Pharmaceuticals' lawsuit alleging it suppressed generic competition for its brand-name medication used to treat a rare cortisol disorder, a California federal judge ruled, saying the claims are not time-barred and Teva has adequately alleged unlawful monopolization.
-
November 15, 2024
Teva Defends Mifepristone Antitrust Case Against Corcept
Teva Pharmaceuticals has asked a California federal judge to reject a bid to dismiss its lawsuit against the maker of a brand-name drug used to treat a rare cortisol disorder, contending its complaint plausibly alleges an illegal scheme to suppress generic competition.